IPH5301 is an Innate Pharma SA program. Its next catalyst is a Readout in Mar 2027.
All upcoming FDA decision dates on the 2026 PDUFA calendar
Sponsor: Innate Pharma SA (IPHA). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.
The next tracked catalyst for IPH5301 is a Readout in Mar 2027.
No FDA decision for IPH5301 is in our archive yet.
Innate Pharma SA (IPHA).
FDA announcements, sponsor press releases and SEC filings. Each FDA decision links its own page, which names its source or says plainly that it has none.